Market Research ReportDec 2, 2022

Peripheral Artery Disease Market

Peripheral Artery Disease Market Research Report: Size, Share, Trend Analysis End User (Hospitals and Clinics, Ambulatory Surgery Centers, End User_Others), DEVICES (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating DrugsDrugs, Blood Clot Preventing Drugs) and By Region (Middle East and Africa, North America, Asia Pacific, Europe, South America) - Growth Outlook & Industry Forecast To 2025

Vertical: HealthcareBase Year: 2018

Book Demo

Executive Summary

Peripheral Artery Disease Market — Snapshot

Market Size (2018)
$16.89B
Projected (2025)
$23.62B
CAGR (2016–2025)
5.0%
Key Players
10+

Peripheral artery diseases (PAD) are the diseases of the blood vessels located outside the brain and heart. PAD occurs when plaque builds up in the arteries that carry blood to the head, organs, and limbs. Plaque is made of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood. PAD usually affects the arteries in the legs, but it also can affect the arteries that carry blood from the heart to the head, arms, kidneys, and stomach.

Factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery diseases, along with increasing product approvals, are driving the growth of the peripheral artery disease market. Additionally, rising cases of diabetes are also driving the growth of the peripheral artery disease market. However, product recalls, and failures are hampering the market growth.

Key Insight

The Peripheral Artery Disease Market market is projected to grow at a CAGR of 5.0% from 2016 to 2025.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
Market Segmentation: The market is analyzed across 3 segments: Hospitals and Clinics, Ambulatory Surgery Centers, End User_Others. Forecasts are provided for each segment from 2016 to 2025.
Competitive Landscape: 10 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Peripheral Artery Disease Market — Growth Trajectory

Scope of the Study

The scope of the global peripheral artery disease market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on treatment type, end user, and region.

Peripheral Artery Disease Market — Growth Trajectory

Hospitals and Clinics

Ambulatory Surgery Centers

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

End User is analyzed as a distinct market dimension.
DEVICES is analyzed as a distinct market dimension.
Drugs is analyzed as a distinct market dimension.

Geographic Analysis

Regional market breakdown

Middle East and Africa market size reached $946.26M in 2016 and is projected to reach $1.34B by 2025, growing at a CAGR of 3.9%.
North America market size reached $5.05B in 2016 and is projected to reach $7.81B by 2025, growing at a CAGR of 5.0%.

Asia Pacific market size reached $3.14B in 2016 and is projected to reach $5.14B by 2025, growing at a CAGR of 5.6%.
Europe market size reached $4.84B in 2016 and is projected to reach $7.35B by 2025, growing at a CAGR of 4.7%.
South America market size reached $1.31B in 2016 and is projected to reach $1.99B by 2025, growing at a CAGR of 4.7%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Peripheral Artery Disease Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+

Research Process

Historical data (2016–2018) and forecast period (2018–2025)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Peripheral Artery Disease Market — Competitive Analysis

The global peripheral artery diseases market is a very attractive and profitable market, both for existing players as well as new entrants. At the same time, intense rivalry among existing competitors has been observed. Our analysis revealed that market players have adopted different strategies to increase their business and position in the global peripheral artery disease market. In recent years, strategic movements made by major players were product launches, acquisitions, and strategic agreements, which have been used as market penetration strategies and to reduce competition.

Companies are now entering into acquisitions, collaborations, product approvals, product launches and expansions to neutralize growing competition from customers, competitors, and to tackle the changing market dynamics. For instance, in October 2019, Koninklijke Philips N.V announced the launch of 200 mm and 150 mm balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio for the treatment of peripheral artery disease patients. Likewise, on September 2019, Terumo Medical Corporation announced the introduction of new R2P MISAGO RX self-expanding peripheral stent. The introduction of this product helps physicians to bring the benefits associated with a radial access approach to patients with PAD.

There are numerous players operating in this market all over the globe. Most of these players exist in the Americas and Europe. There are several large and small market players present in the market which provide a wide range of products for various applications. Medtronic, Koninklijke Philips N.V., Becton, Dickinson and Company, Boston Scientific, Cardinal Health, B. Braun Melsungen AG and Terumo Medical Corporation are the major players in the global peripheral artery disease market, contributing a major share of the total global market.

Threat of New Entrants

There are some mandatory regulatory standards to enter into the drugs and devices market. The threat of new entrants is medium in the peripheral artery disease market. The brand loyalty is medium in the peripheral artery disease market and there many established players in the market, which creates difficulties for newcomers to enter this market.

Bargaining Power of Suppliers

In the global peripheral artery disease market, suppliers are raw materials manufacturers for drug manufacturing companies. The bargaining power of suppliers is low as there is a high number of suppliers in the peripheral artery disease market. Additionally, the switching cost is low as no supplier can influence the prices and exercise control in the industry, which makes the bargaining power low.

Threat of Substitutes

The threat of substitutes in the global peripheral artery disease market is low because of the advantages that peripheral artery disease devices offer. Additionally, quality and trust issues and excellent service provided by the existing players restrict the threat by the substitutes. Also, the low-medium degree of switching costs may minimize the threat of substitutes.

Bargaining Power of Buyers

The bargaining power of buyers is moderate in the global peripheral artery disease market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising prevalence of peripheral artery diseases. Additionally, the presence of providers is also increasing, which makes the bargaining power of buyers moderate due to the low switching costs.

Intensity of Rivalry

The degree of competition in the global peripheral artery disease market is considered to be medium to high. Differentiation among existing players and the introduction of the newer products is increasing the intensity of rivalry in the market. Peripheral artery disease drugs and device manufacturing companies are trying to develop products with high quality, services, and enhanced safety to increase the demand for these products in developed countries and developing regions. Players are engaged in partnering with established organizations and welcoming tie-ups to overcome the competition. Moreover, the players are also developing advanced products for differentiating their brand from competitors.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Peripheral Artery Disease Market.

Regional Market Size (USD Mn)

Market estimates by geography (2025)

USD Mn

InsightNorth America leads with $7.81B by 2025, while Asia Pacific is projected to grow fastest at a 5.6% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2016	2018	2025	CAGR	SHARE
Middle East and Africa	$946.26M	$1.21B	$1.34B	3.9%	6%
North America	$5.05B	$6.56B	$7.81B	5.0%	33%
Asia Pacific	$3.14B	$3.92B	$5.14B	5.6%	22%
Europe	$4.84B	$6.24B	$7.35B	4.7%	31%
South America	$1.31B	$1.71B	$1.99B	4.7%	8%
Total	$15.29B	$19.64B	$23.62B	5.0%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2025)

Hospitals and Clinics

Ambulatory Surgery Centers

End User_Others

0371013

Hospitals and Clinics47%
Ambulatory Surgery Centers37%
End User_Others15%

Total Market Size

$23.62B

Market by Segment (2025)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Hospitals and Clinics	$11.21B	4.9%	47%
Ambulatory Surgery Centers	$8.77B	5.4%	37%
End User_Others	$3.64B	4.0%	15%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Peripheral Artery Disease Market — Key Findings

Analytical insights on Peripheral Artery Disease Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Peripheral Artery Disease Market market is projected to reach $23.62B by 2025, growing at 5.0% CAGR. The Hospitals and Clinics segment holds the largest share.

Market Dynamics

Likewise, growth in emerging markets would serve as an opportunity for market growth.

Market Drivers

The aging population is highly prone to degenerative diseases and chronic illnesses which eventually leads to a rise in diagnosis and treatment. PAD is caused due to buildup of plaque that causes arteries to narrow which eventually limits the flow of oxygen-rich blood to organs and other parts of the body. According to a study by the American Heart Association in 2016, the prevalence of PAD was 6.6% in patients aged 55 to 59 and was about 59.6% in patients aged 85 years or older in the US. The prevalence of PAD affects approximately 5 to 10 million Americans and is a leading cause of disability among people more than 50 years and those with diabetes in the US. According to the National Center for Biotechnology Information, the prevalence of PAD increases with age; it occurs in 3% of people less than 60 years, but its prevalence increased to 15% to 20% among individuals greater than 70 years in 2017 globally. According to the World Health Organization, by 2050, the world’s population aged 60 years and older is expected to be 2 billion, up from 900 million in 2015. Furthermore, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above in 2018.

This rise in the aging population will lead to a rise in PAD cases which will eventually lead to growth in the peripheral artery disease market.

Market Opportunities

Developing economies pose an opportunity for various markets as they have undeveloped research & development sector owing to which they are unable to address upcoming health challenges. In spite of huge demand, the African region is dependent on imported medicines and other health technologies. Although there is a high requirement of treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region. The National Center for Biotechnology Information stated that Peripheral artery disease (PAD), affected approximately 202 million people worldwide in 2019, among which more than two-thirds reside in low- and middle-income countries (LMIC). Moreover, The Lancet stated that peripheral artery disease remains largely undiagnosed and untreated worldwide because a large proportion of patients have the asymptomatic disease.

Hence the rising need for the treatment of peripheral artery disease in developing economies act as an opportunity for the growth of the market.

Market Restraints

A product recall is a request to return a product after the discovery of safety issues or product defects that might endanger the consumer or put the maker/seller at risk of legal action. Product recalls of devices meant for peripheral artery disease by the FDA has led to a dip in the growth of the peripheral artery disease market. For instance, the Food and Drug Administration (FDA) has issued a safety alert regarding the increased risk of death associated with the use of paclitaxel-coated balloons and paclitaxel-eluting stents for the treatment of peripheral arterial disease (PAD).

Additionally, Bard Peripheral Vascular sent an urgent Class I medical device recall notification for its LifeStent Solo vascular stent. This stent caused serious health consequences, including possible complications of bleeding, loss of limb, heart attack, stroke, vascular surgery and/or death. Similar product recalls during the forecast period are likely to hamper market growth.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2025)

Value (USD Mn)

Hospitals and Clinics

Ambulatory Surgery Centers

End User_Others

Companies

Key companies profiled in Peripheral Artery Disease Market

Profiles of 106 companies operating in the Peripheral Artery Disease Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 106 of 106 companies

Cardinal H

Cardinal Health

Healthcare

Company Headquarters: Ohio, US Founded: 1971 Workforce: ~50,000 Company Working: Cardinal Health is a global, integrated healthcare services and products company. The firm provides customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physicians’ offices worldwide. It operates through two business segments, namely, medical products and pharmaceuticals. Through these segments, it offers cost-effective solutions that enhance the supply chain efficiency from hospital to home. It connects patients, providers, payers, pharmacists, and manufacturers for integrated care coordination and better patient management. Through its services and products, it serves nearly 85% of hospitals, more than 26,000 pharmacies, and more than 10,000 specialty physician offices and clinics across the US. In the fiscal year 2018, nearly 50,000 global employees operated in more than 46 countries.

Terumo Medical Corporation

Healthcare

Company Headquarters: Tokyo, Japan Founded: 1921 Workforce: 25,000 Company Working: Terumo Medical Corporation delivers innovative health solutions and provides breakthrough solutions and technologies. The company is involved in manufacturing and sales of medical products and equipment, such as pharmaceuticals, nutritional food supplements, disposable medical devices, vascular grafts, and blood glucose monitoring systems, among others. It has a market presence in over 160 countries in the world. It operates its business through three segments, namely, cardiac and vascular company, blood management company, and general hospital company. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral endovascular and urological treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy.

Boston Scientific Corporation

Healthcare

Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.

Company Headquarters: Berlin, Germany Founded: 1963 Workforce: ~9,000 Company Working: Biotronik is a leading global medical device company with products and services that improve and save the lives of patients suffering from endovascular and cardiovascular diseases. The company’s technologies enable physicians around the world to provide patients the highest standard of care. Its medical devices are created by engineers and designers in Germany, the US, Switzerland, and Singapore. The company is a Golden Goose in the US because of its medium to strong market share, strong profit margins, and slower revenue growth than some of its competitors in the Medical Device Manufacturing industry, where it accounts for an estimated 0.5% of total industry revenue. The company research, develops, and manufactures in technologically advanced countries, including Germany, Switzerland, the US, and Singapore.

United States, North America

B. Braun M

B. Braun Melsungen AG

United States, North America

Page 1 of 18

…

Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Peripheral Artery Disease Market

Peripheral Artery Disease Market Research Report: Size, Share, Trend Analysis End User (Hospitals and Clinics, Ambulatory Surgery Centers, End User_Others), DEVICES (Angioplasty Balloon, Angioplasty Stents (Stenting), Catheters, Plaque Modification Devices (Atherectomy), Hemodynamic Flow Alteration Devices, Others), Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating DrugsDrugs, Blood Clot Preventing Drugs) and By Region (Middle East and Africa, North America, Asia Pacific, Europe, South America) - Growth Outlook & Industry Forecast To 2025

Starting from

$4,950

Peripheral Artery Disease Market

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Peripheral Artery Disease Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Peripheral Artery Disease Market — Competitive Analysis

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Market Performance Trend

Peripheral Artery Disease Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Peripheral Artery Disease Market — Competitive Analysis

Regional Market Data

Segment Revenue (2025)

Segment Market Share

Market by Segment (2025)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2025)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription